Shares of Transenterix Inc (NYSEAMERICAN:TRXC) traded up 1.2% during mid-day trading on Tuesday . The company traded as high as $1.89 and last traded at $1.64. 1,371,207 shares were traded during mid-day trading, a decline of 46% from the average session volume of 2,518,821 shares. The stock had previously closed at $1.66.
A number of analysts have issued reports on the stock. BTIG Research reiterated a “hold” rating on shares of Transenterix in a research note on Monday, December 18th. Zacks Investment Research cut shares of Transenterix from a “hold” rating to a “sell” rating in a research note on Thursday, January 11th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $2.61.
The firm has a market capitalization of $354.65, a P/E ratio of -1.84 and a beta of 2.12.
Institutional investors have recently modified their holdings of the company. Ladenburg Thalmann Financial Services Inc. increased its position in Transenterix by 87.8% during the third quarter. Ladenburg Thalmann Financial Services Inc. now owns 79,150 shares of the medical instruments supplier’s stock worth $113,000 after acquiring an additional 37,000 shares during the period. Virtu Financial LLC bought a new position in Transenterix during the fourth quarter worth $109,000. Bank of New York Mellon Corp increased its position in Transenterix by 94.0% during the fourth quarter. Bank of New York Mellon Corp now owns 119,584 shares of the medical instruments supplier’s stock worth $231,000 after acquiring an additional 57,944 shares during the period. Raymond James Financial Services Advisors Inc. bought a new position in Transenterix during the fourth quarter worth $113,000. Finally, Iguana Healthcare Management LLC bought a new position in Transenterix during the fourth quarter worth $241,000.
Transenterix Company Profile
TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.
Receive News & Ratings for Transenterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix and related companies with MarketBeat.com's FREE daily email newsletter.